List
May 10 (Wed) 14:30~16:00, Rm.403
Session 4. Belgium Life Sciences Seminar
The seminar, followed by the celebrating the first joint workshop and the signing of a new Memorandum of Understaning between Korea Research Institute of Bioscience and Biotechnology (KRIBB) and Milner Therapeutics Insitute at University of Cambridge (MTI), which took place on November, 2023 in Cambridge, U.K, focuses on bringing together experts to discuss and to share the progress, advances and opportunities of KRIBB-MTI joint research around gene therapy, genome editing, stem cell research and computational biology in biomedicine. Further discussion based on applying one of the U.K.'s finest digital biotech venture models to Kor-U.K. multilateral cooperation outcomes is arranged as well.
Pre-Registration
- Session Chair
- Janghwan Kim Principal Researcher, Stem Cell Convergence Research Center, Korea Research Institue of Bioscience and Biotechnology (KRIBB)
- Session Introduction
- Janghwan KimPrincipal Researcher, Stem Cell Convergence Research Center, Korea Research Institue of Bioscience and Biotechnology (KRIBB)
- 13 : 30 ~ 13 : 40
- NIHR Support to the Life Sciences Industry
- Sajni HariaBusiness Development Manager, Coordinating Centre, National Institute of Health and Care Research
- 13 : 40 ~ 14 : 20
- Label-free Bio-imaging Technologies for Gene and Cell Therapy
- Tae Geol LeePrincipal Researcher, Nanobio Measurement Group, Korea Research Institute of Standards and Science
- 14 : 20 ~ 15 : 00
- Platform Development for Anticancer CAR-NK Gene Therapy
- Tae-Don KimPrincipal Researcher, Immunotherapy Research Center, Korea Reseasrch Institute of Bioscience and Biotechnology
- 15 : 20 ~ 16 : 00
- Cambridge Biomedical Cluster, New Paradigm in Therapeutics Research (pre-recorded)
- Namshik HanCo-founder, Chief Technology Officer, CardiaTec Biosciences
- 16 : 00 ~ 16 : 40
- Comprehensive Q&A, Discussion
- a aa, a, a
- 16 : 40 ~ 17 : 00